← Leaderboards
Robert Thomas Woodland
Univ Of Massachusetts Med Sch Worcester
$5,789,549
Attributed
$5,789,549
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $829K · FY2005–16$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,789,549 · 5
By mechanism
R01$4,562,024 · 2
R21$1,227,525 · 3
Top collaborators
No co-investigators on record.
Most similar at Univ Of Massachusetts Med Sch Worcester
Same institution · by research overlap
- David G Lambright$8,969,021
- Katherine A Fitzgerald$21,686,859
- Anthony Carruthers$7,855,968
- Ravindra N Singh$7,400,239
- William Edward Theurkauf$12,443,498
Others in their field
Top investigators on “B-Lymphocytes”
- Barton F Haynes · Duke University$400,419,833
- Lawrence Corey · Fred Hutchinson Cancer Center$83,920,398
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$83,920,398
- Dan H. Barouch · Fred Hutchinson Cancer Center$66,039,430
- Dennis R. Burton · Scripps Research Institute$63,566,673
- Rafi Ahmed · Emory University$62,743,001
Research focus
B-LymphocytesReconstitutionResponseAntigensImmuneCellsInfectionT-LymphocyteIn VivoLymphocyteImmunizationImmune ResponseImmune SystemVaccinationVaccinesResearch StudyPolysaccharidesAntibodiesLaboratory MouseLigandsAffinityLaboratoriesBaseDesign
Grant awards (20)
Modeling human anti-viral humoral responses in the young and elderly$209,375
R21 · FY2016 · AI · contact PI
Modeling human anti-viral humoral responses in the young and elderly$251,250
R21 · FY2015 · AI · contact PI
HIV vaccine development using humanized mice$403,066
R01 · FY2013 · AI · contact PI
HIV vaccine development using humanized mice$403,066
R01 · FY2012 · AI · contact PI
HIV vaccine development using humanized mice$403,066
R01 · FY2011 · AI · contact PI
HIV vaccine development using humanized mice$407,138
R01 · FY2010 · AI · contact PI
HIV vaccine development using humanized mice$31,894
R01 · FY2010 · AI · contact PI
Immunodeficiencies that impair lymphocyte survival$490,372
R01 · FY2009 · AI · contact PI
HIV vaccine development using humanized mice$338,656
R01 · FY2009 · AI · contact PI
Immunodeficiencies that impair lymphocyte survival$374,973
R01 · FY2008 · AI · contact PI
Immunodeficiencies that impair lymphocyte survival$382,236
R01 · FY2007 · AI · contact PI
Immunodeficiencies that impair lymphocyte survival$162,500
R01 · FY2007 · AI · contact PI
Immunodeficiencies that impair lymphocyte survival$393,253
R01 · FY2006 · AI · contact PI
Immunodeficiencies that impair lymphocyte survival$344,250
R01 · FY2005 · AI
Human B cell homeostasis in a new transgenic xenochimera$236,950
R21 · FY2005 · AI
Human B cell homeostasis in a new transgenic xenochimera$251,700
R21 · FY2004 · AI
Immunodeficiencies that impair lymphocyte survival$278,250
R21 · FY2003 · AI
IMMUNODEFICIENCIES THAT IMPAIR LYMPHOCYTE SURVIVAL$190,115
R01 · FY2001 · AI
IMMUNODEFICIENCIES THAT IMPAIR LYMPHOCYTE SURVIVAL$20,143
R01 · FY2001 · AI
IMMUNODEFICIENCIES THAT IMPAIR LYMPHOCYTE SURVIVAL$217,296
R01 · FY2000 · AI